Articles related to DEPRESSION

This study emphasizes the potential of MSK1 methylation levels and executive function as key indicators in predicting suicidal ideation among adolescents with major depressive disorder, providing a new dimension to our understanding of suicide risk factors in this age group.

Treatment-resistant depression in older adults requires a nuanced approach, considering coexisting medical and psychiatric conditions. These insights highlight the significance of collaborative care models and the potential of augmentation strategies in achieving remission.

In this video, Dr. Charles Raison reveals how hyperthermia may harness the body’s immune response to combat major depressive disorder, suggesting a potential shift in non-pharmacological treatment strategies.

Zurzuvae represents a novel approach in postpartum depression therapy, with clinical trials revealing substantial symptom reduction within the initial treatment period. This advancement offers a new horizon in PPD management for healthcare professionals.

Rapid-acting antidepressants represent a pivotal development in depression treatment, targeting the glutamatergic system for quicker and more comprehensive symptom relief.

This study underscores the potential of IV ketamine in managing major depressive disorder, especially in patients with a history of multiple antidepressant trials. With a significant percentage achieving response or remission within six weeks, and these benefits sustained over months, ketamine offers a promising avenue for chronic depression management.